================================================================================
EXECUTIVE SUMMARY - 12-WEEK REHABILITATION PROGRAM TEST RESULTS
================================================================================

Generated: 2025-11-12T06:43:45.811Z
Total Users Analyzed: 10
Total Sessions Analyzed: 360

================================================================================
OVERALL STATISTICS
================================================================================

Average Improvement: 19.11%
Users Improved: 9 (90.0%)
Users Declined: 1 (10.0%)
Users Stable: 0

Risk Distribution (Total Sessions):
  Low Risk: 130 (36.1%)
  Moderate Risk: 122 (33.9%)
  High Risk: 108 (30.0%)

Adherence Distribution:
  Good: 8 users
  Fair: 2 users

Data Completeness:
  Average: 81.0%
  Users with 100% completeness: 0
  Users with <70% completeness: 2

================================================================================
INDIVIDUAL USER SUMMARIES
================================================================================

--------------------------------------------------------------------------------
TEST_BEST_PERFORMER
--------------------------------------------------------------------------------
Age: 32 | Beta Blockers: No | Low EF: No

Performance:
  First Score: 80.17
  Last Score: 100.00
  Improvement: +24.73%
  Trend: Strong Positive
  Adherence: Good
  Consistency: Consistent

Risk Profile:
  Low: 36 sessions
  Moderate: 0 sessions
  High: 0 sessions

Key Observations:
  • Overall Performance: Improved by 24.7% over 12 weeks (80.2 → 100.0)
  • Risk Profile: Dominant risk level: Low. Distribution: 36 Low, 0 Moderate, 0 High
  • Trend: Strong Positive trend observed. Consistency: Consistent
  • Adherence: Good adherence to baseline thresholds
  • Health Status: Dominant status: consistent. Strong improvement sessions: 0
  • Baseline Progression: Baseline increased by 21.2% (82.5 → 100.0)
  • Resting Heart Rate: Improved by 4 bpm (58 → 54)
  • Data Quality: Average completeness: 99.3%. Range: 96%-100%. Total HR points: 904
  • Risk Factors: None identified
  • Weekly Consistency: Consistent week-to-week performance
  • Milestones: Achieved score ≥90; 20%+ improvement; 30+ low-risk sessions

--------------------------------------------------------------------------------
TEST_DATA_30PCT
--------------------------------------------------------------------------------
Age: 60 | Beta Blockers: Yes | Low EF: No

Performance:
  First Score: 41.19
  Last Score: 45.74
  Improvement: +11.05%
  Trend: Stable
  Adherence: Fair
  Consistency: Highly Consistent

Risk Profile:
  Low: 0 sessions
  Moderate: 0 sessions
  High: 36 sessions

Key Observations:
  • Overall Performance: Improved by 11.0% over 12 weeks (41.2 → 45.7)
  • Risk Profile: Dominant risk level: High. Distribution: 0 Low, 0 Moderate, 36 High
  • Trend: Stable trend observed. Consistency: Highly Consistent
  • Adherence: Fair adherence to baseline thresholds
  • Health Status: Dominant status: consistent. Strong improvement sessions: 1
  • Baseline Progression: Baseline increased by 4.4% (43.7 → 45.6)
  • Resting Heart Rate: Improved by 2 bpm (71 → 69)
  • Data Quality: Average completeness: 30.1%. Range: 25%-34%. Total HR points: 260
  • Risk Factors: Beta Blockers, Age 60+
  • Weekly Consistency: Highly Consistent week-to-week performance
  • ⚠️ Concerns: 36 high-risk sessions; Low data completeness (<70%)

--------------------------------------------------------------------------------
TEST_DATA_50PCT
--------------------------------------------------------------------------------
Age: 58 | Beta Blockers: Yes | Low EF: No

Performance:
  First Score: 56.32
  Last Score: 65.59
  Improvement: +16.46%
  Trend: Moderate Positive
  Adherence: Good
  Consistency: Highly Consistent

Risk Profile:
  Low: 0 sessions
  Moderate: 36 sessions
  High: 0 sessions

Key Observations:
  • Overall Performance: Improved by 16.5% over 12 weeks (56.3 → 65.6)
  • Risk Profile: Dominant risk level: Moderate. Distribution: 0 Low, 36 Moderate, 0 High
  • Trend: Moderate Positive trend observed. Consistency: Highly Consistent
  • Adherence: Good adherence to baseline thresholds
  • Health Status: Dominant status: consistent. Strong improvement sessions: 0
  • Baseline Progression: Baseline increased by 14.3% (56.6 → 64.7)
  • Resting Heart Rate: Increased by 1 bpm (68 → 69)
  • Data Quality: Average completeness: 49.8%. Range: 46%-55%. Total HR points: 438
  • Risk Factors: Beta Blockers
  • Weekly Consistency: Highly Consistent week-to-week performance
  • ⚠️ Concerns: Low data completeness (<70%)

--------------------------------------------------------------------------------
TEST_DATA_75PCT
--------------------------------------------------------------------------------
Age: 52 | Beta Blockers: No | Low EF: No

Performance:
  First Score: 54.45
  Last Score: 65.61
  Improvement: +20.50%
  Trend: Moderate Positive
  Adherence: Good
  Consistency: Highly Consistent

Risk Profile:
  Low: 0 sessions
  Moderate: 36 sessions
  High: 0 sessions

Key Observations:
  • Overall Performance: Improved by 20.5% over 12 weeks (54.5 → 65.6)
  • Risk Profile: Dominant risk level: Moderate. Distribution: 0 Low, 36 Moderate, 0 High
  • Trend: Moderate Positive trend observed. Consistency: Highly Consistent
  • Adherence: Good adherence to baseline thresholds
  • Health Status: Dominant status: consistent. Strong improvement sessions: 0
  • Baseline Progression: Baseline increased by 12.7% (56.4 → 63.6)
  • Resting Heart Rate: Increased by 1 bpm (67 → 68)
  • Data Quality: Average completeness: 75.5%. Range: 70%-80%. Total HR points: 674
  • Risk Factors: None identified
  • Weekly Consistency: Highly Consistent week-to-week performance
  • Milestones: 20%+ improvement

--------------------------------------------------------------------------------
TEST_DATA_90PCT
--------------------------------------------------------------------------------
Age: 45 | Beta Blockers: No | Low EF: No

Performance:
  First Score: 68.79
  Last Score: 86.78
  Improvement: +26.15%
  Trend: Strong Positive
  Adherence: Good
  Consistency: Consistent

Risk Profile:
  Low: 31 sessions
  Moderate: 5 sessions
  High: 0 sessions

Key Observations:
  • Overall Performance: Improved by 26.2% over 12 weeks (68.8 → 86.8)
  • Risk Profile: Dominant risk level: Low. Distribution: 31 Low, 5 Moderate, 0 High
  • Trend: Strong Positive trend observed. Consistency: Consistent
  • Adherence: Good adherence to baseline thresholds
  • Health Status: Dominant status: consistent. Strong improvement sessions: 0
  • Baseline Progression: Baseline increased by 25.3% (68.7 → 86.0)
  • Resting Heart Rate: Improved by 5 bpm (65 → 60)
  • Data Quality: Average completeness: 90.4%. Range: 85%-95%. Total HR points: 812
  • Risk Factors: None identified
  • Weekly Consistency: Consistent week-to-week performance
  • Milestones: 20%+ improvement; 30+ low-risk sessions

--------------------------------------------------------------------------------
TEST_DECLINING_PERFORMER
--------------------------------------------------------------------------------
Age: 67 | Beta Blockers: Yes | Low EF: Yes

Performance:
  First Score: 41.38
  Last Score: 40.41
  Improvement: -2.34%
  Trend: Moderate Negative
  Adherence: Fair
  Consistency: Consistent

Risk Profile:
  Low: 0 sessions
  Moderate: 0 sessions
  High: 36 sessions

Key Observations:
  • Overall Performance: Declined by 2.3% over 12 weeks (41.4 → 40.4)
  • Risk Profile: Dominant risk level: High. Distribution: 0 Low, 0 Moderate, 36 High
  • Trend: Moderate Negative trend observed. Consistency: Consistent
  • Adherence: Fair adherence to baseline thresholds
  • Health Status: Dominant status: consistent. Strong improvement sessions: 3
  • Baseline Progression: Baseline decreased by 16.7% (42.8 → 35.6)
  • Resting Heart Rate: Increased by 2 bpm (71 → 73)
  • Data Quality: Average completeness: 98.8%. Range: 95%-100%. Total HR points: 897
  • Risk Factors: Beta Blockers, Low EF, Age 60+
  • Weekly Consistency: Consistent week-to-week performance
  • ⚠️ Concerns: 36 high-risk sessions

--------------------------------------------------------------------------------
TEST_GOOD_PERFORMER
--------------------------------------------------------------------------------
Age: 48 | Beta Blockers: No | Low EF: No

Performance:
  First Score: 66.48
  Last Score: 85.47
  Improvement: +28.56%
  Trend: Strong Positive
  Adherence: Good
  Consistency: Consistent

Risk Profile:
  Low: 32 sessions
  Moderate: 4 sessions
  High: 0 sessions

Key Observations:
  • Overall Performance: Improved by 28.6% over 12 weeks (66.5 → 85.5)
  • Risk Profile: Dominant risk level: Low. Distribution: 32 Low, 4 Moderate, 0 High
  • Trend: Strong Positive trend observed. Consistency: Consistent
  • Adherence: Good adherence to baseline thresholds
  • Health Status: Dominant status: consistent. Strong improvement sessions: 0
  • Baseline Progression: Baseline increased by 20.8% (70.8 → 85.6)
  • Resting Heart Rate: Improved by 3 bpm (63 → 60)
  • Data Quality: Average completeness: 98.2%. Range: 95%-100%. Total HR points: 890
  • Risk Factors: None identified
  • Weekly Consistency: Consistent week-to-week performance
  • Milestones: 20%+ improvement; 30+ low-risk sessions

--------------------------------------------------------------------------------
TEST_IMPROVING_DATA
--------------------------------------------------------------------------------
Age: 50 | Beta Blockers: No | Low EF: No

Performance:
  First Score: 66.29
  Last Score: 85.76
  Improvement: +29.37%
  Trend: Strong Positive
  Adherence: Good
  Consistency: Consistent

Risk Profile:
  Low: 31 sessions
  Moderate: 5 sessions
  High: 0 sessions

Key Observations:
  • Overall Performance: Improved by 29.4% over 12 weeks (66.3 → 85.8)
  • Risk Profile: Dominant risk level: Low. Distribution: 31 Low, 5 Moderate, 0 High
  • Trend: Strong Positive trend observed. Consistency: Consistent
  • Adherence: Good adherence to baseline thresholds
  • Health Status: Dominant status: consistent. Strong improvement sessions: 0
  • Baseline Progression: Baseline increased by 26.3% (68.9 → 87.0)
  • Resting Heart Rate: Improved by 4 bpm (66 → 62)
  • Data Quality: Average completeness: 70.8%. Range: 42%-100%. Total HR points: 656
  • Risk Factors: None identified
  • Weekly Consistency: Consistent week-to-week performance
  • Milestones: 20%+ improvement; 30+ low-risk sessions

--------------------------------------------------------------------------------
TEST_MODERATE_PERFORMER
--------------------------------------------------------------------------------
Age: 56 | Beta Blockers: Yes | Low EF: No

Performance:
  First Score: 55.78
  Last Score: 67.63
  Improvement: +21.24%
  Trend: Moderate Positive
  Adherence: Good
  Consistency: Consistent

Risk Profile:
  Low: 0 sessions
  Moderate: 36 sessions
  High: 0 sessions

Key Observations:
  • Overall Performance: Improved by 21.2% over 12 weeks (55.8 → 67.6)
  • Risk Profile: Dominant risk level: Moderate. Distribution: 0 Low, 36 Moderate, 0 High
  • Trend: Moderate Positive trend observed. Consistency: Consistent
  • Adherence: Good adherence to baseline thresholds
  • Health Status: Dominant status: consistent. Strong improvement sessions: 0
  • Baseline Progression: Baseline increased by 15.2% (56.9 → 65.5)
  • Resting Heart Rate: Improved by 1 bpm (69 → 68)
  • Data Quality: Average completeness: 98.1%. Range: 95%-100%. Total HR points: 889
  • Risk Factors: Beta Blockers
  • Weekly Consistency: Highly Consistent week-to-week performance
  • Milestones: 20%+ improvement

--------------------------------------------------------------------------------
TEST_POOR_PERFORMER
--------------------------------------------------------------------------------
Age: 62 | Beta Blockers: Yes | Low EF: Yes

Performance:
  First Score: 42.97
  Last Score: 49.58
  Improvement: +15.38%
  Trend: Stable
  Adherence: Good
  Consistency: Highly Consistent

Risk Profile:
  Low: 0 sessions
  Moderate: 0 sessions
  High: 36 sessions

Key Observations:
  • Overall Performance: Improved by 15.4% over 12 weeks (43.0 → 49.6)
  • Risk Profile: Dominant risk level: High. Distribution: 0 Low, 0 Moderate, 36 High
  • Trend: Stable trend observed. Consistency: Highly Consistent
  • Adherence: Good adherence to baseline thresholds
  • Health Status: Dominant status: consistent. Strong improvement sessions: 0
  • Baseline Progression: Baseline increased by 9.3% (43.2 → 47.2)
  • Resting Heart Rate: Improved by 2 bpm (70 → 68)
  • Data Quality: Average completeness: 98.7%. Range: 95%-100%. Total HR points: 893
  • Risk Factors: Beta Blockers, Low EF, Age 60+
  • Weekly Consistency: Highly Consistent week-to-week performance
  • ⚠️ Concerns: 36 high-risk sessions

================================================================================
END OF REPORT
================================================================================
